Search

everythinglearnresearchcommunity

for

Search:↓

Deep dermal tissue dislocation injury in pigs leads to thicker fibrotic tissue and increased type III collagen, affecting skin repair.

Lupus pneumonitis can mimic tuberculosis and should be considered in diagnoses.

Tislelizumab can cause cutaneous lupus erythematosus.

Targeting NETs may help reduce fibrosis in Crohn's disease.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Fibroblast and immune cell interactions affect tissue repair and fibrosis.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

Polypoid cystitis can mimic bladder cancer but can be effectively treated with surgery, stents, and medication.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

TGF-β1 and TNF-α contribute to lung damage after radiation.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

TB lymphadenitis can occur in people with weakened immune systems, like those with SLE.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

People with weakened immune systems, like those with SLE, are at higher risk for TB.

New scientific advancements offer hope for better treatments for skin fibrosis.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

GRF is not safe for tubal occlusion.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.